SC
VNDA icon

Syon Capital’s Vanda Pharmaceuticals VNDA Stock Holding History

Syon Capital’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125K Buy
+20,401
New +$133K 0.01% 937

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Syon Capital's VNDA Position: Q2 2026 in Review

Syon Capital opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 20,401 shares worth $125K. The stake represents 0.01% of the portfolio and ranks #937 among its holdings.

172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Syon Capital held 20,401 shares of Vanda Pharmaceuticals worth $125K as of Q2 2026.
  • Vanda Pharmaceuticals was a new Syon Capital position in Q2 2026.
  • Vanda Pharmaceuticals made up 0.01% of Syon Capital's portfolio in Q2 2026, its #937 holding.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.